{"id":67753,"name":"TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS","slug":"tiber-creek-group-on-behalf-of-jazz-pharmaceuticals","state":"DC","country":"United States of America","description":"Biopharmaceutical company.","totalSpending":90000,"filings":4,"yearlySpending":[{"year":2025,"income":90000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["B HALL STRATEGIES, LLC"],"lobbyists":["JAMES HALL"],"govEntities":["SENATE"],"sampleDescriptions":["Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues rel","Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues rel","Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues rel","Issues related to Orphan drug coverage under Medicare.","Issues related to Orphan drug coverage under Medicare. General Medicare issues impacting Jazz Pharmaceuticals."]}